Global Gamma-aminobutyric Acid (GABA) Competitive Landscape Professional Research Report 2025

Research Summary

Gamma-aminobutyric acid, commonly known as GABA, is a neurotransmitter that plays a crucial role in regulating brain activity by inhibiting nerve transmission. It is an amino acid that acts as an inhibitory neurotransmitter in the central nervous system, calming overexcited nerve signals and promoting a state of relaxation. GABA receptors are widely distributed in the brain and are involved in various physiological functions, including anxiety regulation, stress response, and sleep cycles. While GABA is naturally produced in the brain, it is also available as a dietary supplement. Some people use GABA supplements to potentially alleviate stress, anxiety, and promote better sleep, although the effectiveness of such supplements is a subject of ongoing research. GABA＇s role in maintaining the balance between excitation and inhibition in the brain makes it a crucial component in the complex network of neurotransmitters influencing mental well-being.

According to DIResearch's in-depth investigation and research, the global Gamma-aminobutyric Acid (GABA) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Gamma-aminobutyric Acid (GABA) include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Sun Pharmaceutical Industries, Lannett, Cipla, Aurobindo Pharma, Zydus Cadila etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Gamma-aminobutyric Acid (GABA). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gamma-aminobutyric Acid (GABA) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gamma-aminobutyric Acid (GABA) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gamma-aminobutyric Acid (GABA) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gamma-aminobutyric Acid (GABA) Include:

Sanofi

Mylan N.V.

Teva Pharmaceutical Industries

Novartis

Aytu BioScience

Dr. Reddy’s Laboratories

Endo Pharmaceuticals

Lupin

Johnson & Johnson Services

Sun Pharmaceutical Industries

Lannett

Cipla

Aurobindo Pharma

Zydus Cadila

Gamma-aminobutyric Acid (GABA) Product Segment Include:

Oral

Parenteral

Intrathecal

Others

Gamma-aminobutyric Acid (GABA) Product Application Include:

Hospital

Specialty Clinic

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Gamma-aminobutyric Acid (GABA) Capacity and Production Analysis

Chapter 3: Global Gamma-aminobutyric Acid (GABA) Industry PESTEL Analysis

Chapter 4: Global Gamma-aminobutyric Acid (GABA) Industry Porter's Five Forces Analysis

Chapter 5: Global Gamma-aminobutyric Acid (GABA) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Gamma-aminobutyric Acid (GABA) Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Gamma-aminobutyric Acid (GABA) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Gamma-aminobutyric Acid (GABA) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources